GeneDx Holdings Corp. logo WGS - GeneDx Holdings Corp.

NEXT EARNINGS: Apr 28, 2026
Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 10
HOLD 1
SELL 0
STRONG
SELL
0
| PRICE TARGET: $157.50 DETAILS
HIGH: $170.00
LOW: $130.00
MEDIAN: $162.50
CONSENSUS: $157.50
UPSIDE: 95.17%
Market Cap: 2.33B
Volume: 1,141,442
Avg Volume: 593,571
52 Week Range: 55.17-170.87
Sector: Healthcare
Industry: Medical - Healthcare Information Services
Beta: 2.02
Last Dividend: $N/A
Exchange: NASDAQ
Country: US
Employees: 1,000
IPO Date: 2020-11-04
EPS (TTM): -0.73
P/E Ratio: -166.38
Revenue (TTM): 427.54M
Total Assets: 523.71M
Total Debt: 60.45M
Cash & Equiv: 105.00M
Rev Growth (5Y): 19.0%
EPS Growth (5Y): N/A
FCF Growth (5Y): N/A
ROCE: -2.8%
Debt/Equity: 0.20

Earnings History

Date EPS Actual EPS Est EPS Surprise Rev Actual Rev Est Rev Surprise
2025-10-28 $0.49 $0.28 +75.0% $116.7M $120.5M -3.1%
2025-07-29 $0.50 $0.10 +400.0% $102.7M $98.6M +4.1%
2025-04-30 $0.28 $0.11 +154.5% $87.1M $85.3M +2.1%
2025-02-18 $0.70 $0.04 +1650.0% $95.6M $79.0M +21.1%
2024-10-29 $0.04 $-0.19 +121.1% $76.9M $80.2M -4.2%
2024-07-30 $-0.11 $-0.26 +57.7% $70.5M $59.3M +18.9%
2024-04-29 $-0.33 $-0.68 +51.5% $62.4M $58.4M +7.0%
2024-02-20 $-0.59 $-0.60 +1.7% $57.4M $55.4M +3.6%

Track Record

Statements >
Metric 2025 2024 2023 2022 2021 2020 2019
Revenue 427.54M 305.45M 202.57M 234.69M 212.19M 179.32M 196.17M
Net Income (21.02M) (52.29M) (175.77M) (548.98M) (245.39M) (241.34M) (29.70M)
EPS -0.73 -1.94 -7.23 -53.63 -74.93 -33.16 -4.26
Total Assets 523.71M 419.38M 418.76M 545.26M 554.09M 251.64M N/A
Total Debt 60.45M 116.17M 119.77M 77.13M 32.85M 43.26M N/A
Cash & Equivalents 105.00M 85.21M 99.68M 137.40M 400.57M 108.13M N/A
Operating Cash Flow 33.28M (28.50M) (180.15M) (319.15M) (190.43M) (93.13M) (18.73M)
Free Cash Flow 14.26M (33.99M) (185.86M) (333.48M) (211.22M) (125.10M) (34.18M)
FCF per Share 0.53 -1.26 -7.64 -32.58 -64.49 -22.23 -6.08
Book Value 308.18M 245.25M 228.02M 253.71M 388.10M 4.39M N/A
Cash & ST Investments 171.28M 141.19M 130.15M 137.40M 400.57M 108.13M N/A
ROC Equity -0.07 -0.21 -0.77 -2.16 -0.63 -55.00 N/A